Response to cytotoxic chemotherapy and overall survival in non-small cell lung cancer patients with positive or negative ERCC1 expression
Author:
Affiliation:
1. Universidade Estadual de Campinas, Brazil
Publisher
FapUNIFESP (SciELO)
Subject
Pulmonary and Respiratory Medicine
Link
http://www.scielo.br/pdf/jbpneu/v44n3/1806-3713-jbpneu-44-03-00245.pdf
Reference6 articles.
1. Genetic polymorphism of XRCC1 Arg399Gln is associated with survival in non-small-cell-lung cancer patients treated with gemcitabine/platinum;Liao WY;J Thorac Oncol,2012
2. Histology-related associations of ERCC1, RRM1, and TS biomarkers in patients with non-small-cell lung cancer implications for therapy;Maus MK;J Thorac Oncol,2013
3. Randomized Prospective Biomarker Trial of ERCC1 for Comparing Platinum and Nonplatinum Therapy in Advanced Non-Small-Cell Lung Cancer ERCC1 Trial (ET);Lee SM;J Clin Oncol,2017
4. The place of excision repair cross complementation 1 (ERCC1) in surgically treated non-small cell lung cancer;Breen D;Eur J Cardiothorac Surg,2008
5. ERCC1 expression is a predictor of survival in resected patients with non-small cell lung cancer;Simon GR;Chest,2005
Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Meta-Analysis of ERCC1 Protein Expression and Platinum Chemosensitivity in Non-Small-Cell Lung Cancer;Evidence-Based Complementary and Alternative Medicine;2020-04-30
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3